2021
DOI: 10.3390/medicina57040350
|View full text |Cite
|
Sign up to set email alerts
|

Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis

Abstract: Background and Objectives: Laboratory liver abnormalities can be observed in patients affected with polymyalgia rheumatica (PMR) and/or giant cell arteritis (GCA), especially with a cholestatic pattern. The first objective of our review article is to discuss the potential link between antimitochondrial antibodies (AMA) and/or primary biliary cholangitis (PBC) and PMR/GCA, according to the evidences of literature. The second objective is to discuss the association of PMR/GCA with the other rheumatic diseases ha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 49 publications
(55 reference statements)
0
0
0
Order By: Relevance
“…Approximately 10 to 20% of PMR cases are associated with giant cellular arteritis (GCA), a large vessel vasculitis (11). PMR can also reveal other inflammatory or autoimmune diseases, such as rheumatoid arthritis (12,13), late onset spondylarthritis (14,15) or various autoimmune diseases, such as lupus and primary biliary cholangitis (16)(17)(18)(19)(20).…”
Section: Polymyalgia Rheumaticamentioning
confidence: 99%
“…Approximately 10 to 20% of PMR cases are associated with giant cellular arteritis (GCA), a large vessel vasculitis (11). PMR can also reveal other inflammatory or autoimmune diseases, such as rheumatoid arthritis (12,13), late onset spondylarthritis (14,15) or various autoimmune diseases, such as lupus and primary biliary cholangitis (16)(17)(18)(19)(20).…”
Section: Polymyalgia Rheumaticamentioning
confidence: 99%